alpha-4/beta-7 integrin inhibitors (Jouveinal)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealpha-4/beta-7 integrin inhibitors (Jouveinal)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-7 inhibitors
TargetsIntegrin alpha-4/beta-7
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstitut de Recherche Jouveinal SA (IRJ)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitut de Recherche Jouveinal SA (IRJ)Pfizer Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A